心拍出量モニター市場：2024年～2031年

概要

世界の心拍出量モニター市場は、2023年に15億米ドルに達し、2031年までには22億3,000万米ドルに達し、2024年から2031年の予測期間中にCAGR5.2％で成長すると予測されています。

心拍出量モニターは、患者の心血管系機能に関する重要な情報を提供するため、臨床医学、特にクリティカルケアや心臓病学において重要な役割を果たしています。心拍出量モニターの重要性は、ヘルスケアプロバイダーが患者の管理と治療に関して十分な情報に基づいた意思決定を行う際に役立つ点にあります。心拍出量モニタリングにより、患者の治療戦略をカスタマイズすることができます。

患者個々の心血管系のニーズに合わせて治療を適応させることで、医療従事者は患者の転帰を最適化することができます。治療の有効性を評価し、心不全の増悪を避けるために、心拍出量の綿密なモニタリングが心不全患者にしばしば必要とされます。血行動態の不安定性を早期に発見し治療することで、臓器不全、組織低酸素症、長期入院を回避することができます。

市場力学：

促進要因

心血管疾患の有病率の増加

心血管疾患の有病率の増加は、市場の成長を促進します。心血管疾患および障害の有病率の上昇により、心拍出量モニターを含むモニタリングおよび管理技術の向上が求められています。心血管疾患の増加により、市場は急速に拡大しています。例えば、米国疾病予防管理センターによると、心臓病は米国の男性、女性、ほとんどの人種・民族の人々の主な死因です。米国では33秒に1人が心血管疾患で死亡しています。米国では約69万5,000人が心臓病で死亡しており、これは死亡者5人に1人の割合です。

さらに、英国心臓財団の2023年の発表によると、世界中で約6億2,000万人が心臓病や循環器疾患を患っており、この数はライフスタイルの変化、高齢化、人口の増加、心臓発作や脳卒中からの生存率の向上により増加しており、この傾向が続けば、今後も増加し続けると思われます。このように心血管疾患の増加は市場成長の原動力となっています。さらに、心血管系出力モニターは、医療従事者が賢明な判断を下し、悪い結果を避けるために必要な情報を提供することで、患者の安全性を向上させます。より低侵襲で高精度な心拍出量モニターリングツールの開発は、モニタリング技術の継続的な開発によって可能になり、臨床現場でより利用しやすく有用なものとなっています。

抑制要因

心拍出量モニターに関連する高コストなどの要因が市場を阻害すると予想されます。心拍出量をモニタリングする装置、特に侵襲的なものは、購入と操作の両方で価格が高くなる可能性があります。特に医療資源が限られているヘルスケア環境では、初期費用が高く、消耗品やキャリブレーションに定期的に費用がかかるため、使用が妨げられる可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 心血管デバイスの普及率増加
  • 抑制要因
    • 心拍出量モニターに関連する高コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• アンメットニーズ
• PESTEL分析
• 特許分析
• SWOT分析

第6章 タイプ別

• 侵襲性心拍出量モニター
• 非侵襲性心拍出量モニター
• 低侵襲心拍出量モニター
• その他

第7章 技術別

• 肺動脈カテーテル
• 熱希釈パルス輪郭解析法
• リチウム希釈法
• 動脈波形解析法
• ドップラー
• その他

第8章 エンドユーザー別

• 病院
• 心臓センター
• 外来手術センター
• その他

第9章 地域別

• 北米
  • 規模分析・前年比成長率分析（%）：流通チャネル別
    • 米国
    • カナダ
    • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市場ポジショニング / シェア分析
• M&A分析

第11章 企業プロファイル

• Edwards Lifesciences Corporation
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主要な発展
• Masimo
• Getinge Inc.
• Nihon Kohden Corporation
• Deltex Medical Group plc
• GE Healthcare
• Koninklijke Philips N.V
• Schwarzer Cardiotek
• Tenko Medical System Corp
• Osypka Medical（*LIST NOT EXHAUSTIVE）

第12章 付録

Overview

The global cardiac output monitors market reached US$ 1.5 billion in 2023 and is expected to reach US$ 2.23 billion by 2031, growing at a CAGR of 5.2% during the forecast period 2024-2031.

Cardiac output monitors play a crucial role in clinical medicine, particularly in critical care and cardiology settings, as they provide essential information about a patient's cardiovascular function. The importance of cardiac output monitoring lies in its ability to help healthcare providers make informed decisions regarding patient management and treatment. Cardiac output monitoring allows patient treatment strategies to be customized.

By adapting therapies to a patient's individual cardiovascular needs, medical professionals can optimize patient outcomes. Close cardiac output monitoring is frequently necessary for patients with heart failure in order to evaluate the efficacy of treatment and avoid decompensation. Organ failure, tissue hypoxia, and extended hospital stays can all be avoided with the early identification and treatment of hemodynamic instability.

Market Dynamics: Drivers

Increasing prevalence of cardiovascular diseases

The rising prevalence of cardiovascular diseases propels the market growth. Improved monitoring and management technologies, including cardiac output monitors, are required due to the rising prevalence of cardiovascular diseases and disorders. The market is expanding rapidly as a result of the rise in cardiovascular diseases. For instance, according to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. One person dies every 33 seconds in the United States from cardiovascular disease. About 695,000 people in the United States died from heart disease, that's 1 in every 5 deaths.

Moreover, according to the British Heart Foundation 2023, stated that around 620 million people live with heart and circulatory diseases across the world - this number has been rising due to changing lifestyles, an aging, and growing population, and improved survival rates from heart attacks and strokes - and will continue to rise if these trends continue. Thus rising of the cardiovascular diseases helps to drive the market growth. Additionally, cardiovascular output monitors improve patient safety by giving healthcare professionals the information they need to make wise decisions and avoid negative outcomes. The development of less invasive and more precise cardiac output monitoring tools has been made possible by ongoing developments in monitoring technology, making them more available and useful in clinical settings.

Restraints

Factors such as high costs associated with cardiac output monitors are expected to hamper the market. The devices for monitoring cardiac output, particularly invasive ones, can be pricey for both purchase and operation. Their use may be hindered, especially in healthcare settings with limited resources, due to high upfront costs and recurring costs for consumables or calibration.

Segment Analysis

The global cardiac output monitors market is segmented based on type, technology, end-user, and region.

The non-invasive cardiac output monitors accounted for approximately 46.7% of the global cardiac output monitors market share.

The non-invasive cardiac output monitors segment is expected to hold the largest market share over the forecast period. In this segment, the features and launches of new products would drive this market.

A patient's cardiovascular function can be evaluated with non-invasive cardiac output monitors without a need for invasive treatments. These monitors offer useful data on cardiac output, or the amount of blood the heart pumps each minute, as well as other associated hemodynamic parameters. For instance, using invasive procedures like catheterization is not necessary when using non-invasive monitoring techniques like impedance cardiography or Doppler ultrasonography. As a result, there is a lower possibility of problems, infections, and patient discomfort brought on by invasive monitoring methods.

They aid in the early detection of abnormalities in the heart function of a patient. Clinicians can see problems like heart failure exacerbations or shock states and act quickly by continually monitoring cardiac output and associated metrics. Moreover, on April 25, 2022, with the addition of cardiac output, stroke volume, heart rate variability, and left ventricular ejection time to its VitalStream non-invasive patient monitoring platform, Caretaker Medical, a provider of wireless patient monitoring technologies, received FDA 510(k) clearance.

Geographical Analysis

North America accounted for approximately 43.8% of the global cardiac output monitors market share

North America region is expected to hold the largest market share over the forecast period. The rising incidence of cardiovascular diseases, approvals, and increase in the healthcare expenses in this region, help to propel the market.

For instance, according to the National Institute of Health, approximately 82.6 million people in the United States currently have one or more forms of cardiovascular disease (CVD), making it a leading cause of death for both men and women. Common types of cardiovascular disease include coronary heart disease (CHD), stroke, hypertension, and congestive heart failure. An estimated 16.3 million Americans aged 20 and older have CHD, a prevalence of 7 percent.

The prevalence for men is 8.3 percent and for women is 6.1 percent. About 7 million Americans aged 20 or older have had a stroke. Each year approximately 610,000 experience their first stroke and another 185,000 experience a recurrence. Approximately 87 percent of all strokes are ischemic of which 10 percent result from intracerebral hemorrhage and 3 percent result from subarachnoid hemorrhage.

Market Segmentation

By Type

Invasive Cardiac Output Monitors

Non-Invasive Cardiac Output Monitors

Minimally Invasive Cardiac Output Monitors

Others

By Technology

Pulmonary Artery Catheter

Thermodilution Pulse Contour Analysis Technique

Lithium Dilution Technique

Arterial Waveform Analysis Technique

Doppler

Others

By End-User

Hospitals

Cardiac Centers

Ambulatory Surgical Centers

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Competitive Landscape

The major global players in the global cardiac output monitors market include Edwards Lifesciences Corporation, Masimo, Getinge Inc, Nihon Kohden Corporation, Deltex Medical Group plc, GE Healthcare, Koninklijke Philips N.V, Schwarzer Cardiotek, Tenko Medical System Corp, Osypka Medical among others.

Key Developments

In October 2023, Masimo announced the CE mark, under the European Union Medical Device Regulation, for the LiDCO(R) board-in-cable (BIC) module. The LiDCO BIC module is designed to connect to multi-patient monitoring platforms, like the Masimo Root(R) Patient Monitoring and Connectivity Hub, to provide advanced hemodynamic monitoring. With this solution, clinicians can easily add LiDCO hemodynamic monitoring

In April 2023, French medical device company, Vygon India launched its advanced hemodynamic monitoring system, Mostcare Up, in North India during a Society of Critical Care Medicine (ISCCM) symposium in Chandigarh. The Mostcare Up system is a minimally invasive arterial pressure-based monitor powered by a patented algorithm based on the Pressure Recording Analytical Method (PRAM). It is the only monitor that can follow even the slightest hemodynamic variations in real time and from beat to beat.

Why Purchase the Report?

To visualize the global cardiac output monitors market segmentation based on type, technology, end-user, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development

Excel data sheet with numerous data points of global cardiac output monitors market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global cardiac output monitors market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Technology
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Prevalence of Cardiovascular Devices
  • 4.1.2. Restraints
    • 4.1.2.1. High Cost Associated with the Cardiac Output Monitors
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Unmet Needs
• 5.6. PESTEL Analysis
• 5.7. Patent Analysis
• 5.8. SWOT Analysis

6. By Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 6.1.2. Market Attractiveness Index, By Type
• 6.2. Invasive Cardiac Output Monitors *
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Non-Invasive Cardiac Output Monitors
• 6.4. Minimally Invasive Cardiac Output Monitors
• 6.5. Others

7. By Technology

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 7.1.2. Market Attractiveness Index, By Technology
• 7.2. Pulmonary Artery Catheter *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Thermodilution Pulse Contour Analysis Technique
• 7.4. Lithium Dilution Technique
• 7.5. Arterial Waveform Analysis Technique
• 7.6. Doppler
• 7.7. Others

8. By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Cardiac Centers
• 8.4. Ambulatory Surgical Centers
• 8.5. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.2.5. Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.7.1. U.S.
    • 9.2.7.2. Canada
    • 9.2.7.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. UK
    • 9.3.6.3. France
    • 9.3.6.4. Italy
    • 9.3.6.5. Spain
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Edwards Lifesciences Corporation *
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Masimo
• 11.3. Getinge Inc.
• 11.4. Nihon Kohden Corporation
• 11.5. Deltex Medical Group plc
• 11.6. GE Healthcare
• 11.7. Koninklijke Philips N.V
• 11.8. Schwarzer Cardiotek
• 11.9. Tenko Medical System Corp
• 11.10. Osypka Medical (*LIST NOT EXHAUSTIVE)

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us